Dr. rer. nat. Oliver Scholle

• Versorgungsforschung
• Arzneimittelanwendungsforschung
• Pharmakoepidemiologie
• Neuropsychiatrische Erkrankungen (v.a. ADHS)

• Deutsches Netzwerk Versorgungsforschung e.V. (DNVF)
• Deutsche Gesellschaft für Epidemiologie (DGEpi)
• International Society for Pharmacoepidemiology (ISPE)
• Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

• Anwendung von Opioid-haltigen Arzneimitteln in Deutschland
• Studie zur Analyse der regionalen Unterschiede bei der Antibiotika- Verordnung
• Superthyreose: Ãœberversorgung von Schilddrüsenerkrankungen in Deutschland
• Weiterentwicklung, Optimierung und Anwendung eines Algorithmus zur Detektion schwerwiegender unerwünschter Arzneimittelwirkungen auf Basis von Versichertendaten
• Werden Kinder und Jugendliche mit Schizophrenie frühzeitig diagnostiziert und optimal therapiert? - Eine Untersuchung auf Basis von GKV-Abrechnungsdaten

Ausgewählte BIPS-Veröffentlichungen

• Zeitschriftenartikel mit peer-review

• Chan AYL, Bahmanyar S, Beyene K, Bushnell G, Carleton B, Chan AHY, Cook S, Crystal S, Furu K, Gadzhanova S, García Poza P, Gini R, Giometto S, Harrison J, Haug U, Hsu C, Hjördisar Jónsdóttir HL, Kai J, Karlstad Ø, Kim JH, Kubota K, Chia-Cheng Lai E, Lee H, Lau WCY, Li KH, Lucenteforte E, Géric M, Neumann A, Pate V, Pottegård A, Qureshi N, Rasmussen L, Reutfors J, Roughead EE, Saastamoinen L, Sato T, Scholle O, Schuiling-Veninga CCM, Shen C-Y, Shin J-Y, Stürmer T, Taxis K, Tuccori M, Weng S, Wong KH.W, Zoega H, Man KKC, Wong ICK. International trends in opioid prescribing by age and sex from 2001 to 2019: An observational study using population-based databases from 18 countries and one special administrative region. CNS Drugs. 2025;39(11):1173-1185.
  https://doi.org/10.1007/s40263-025-01215-2
• Bachmann CJ, Scholle O, Bliddal M, DosReis S, Odsbu I, Skurtveit S, Wesselhoeft R, Vivirito A Zhang, Chengchen, Scott S. Recognition and management of children and adolescents with conduct disorder: A real-world data study from four western countries. Child and Adolescent Psychiatry and Mental Health. 2024;18:18.
  https://doi.org/10.1186/s13034-024-00710-6
• Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Comparative analysis of outpatient antibiotic prescribing in early life: A population-based study across birth cohorts in Denmark and Germany. Infectious Diseases and Therapy. 2024;13(2):299-312.
  https://doi.org/10.1007/s40121-024-00916-3
• Schüz B, Scholle O, Haug U, Tillmann R, Jones C. Drivers of district-level differences in outpatient antibiotic prescribing in Germany: A qualitative study with prescribers. BMC Health Services Research. 2024;24:589.
  https://doi.org/10.1186/s12913-024-11059-z
• Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, Kaplan S, McMahon AW, Movva N, Raman SR, Scholle O, Suh M, Sun JW, Horton DB. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Pharmacoepidemiology and Drug Safety. 2024;33(1):e5695.
  https://doi.org/10.1002/pds.5695
  https://repository.publisso.de/resource/frl%3A6525229
• Dörks M, Bachmann CJ, Below M, Hoffmann F, Paschke LM, Scholle O. Trends in antipsychotic use among children and adolescents in Germany: A study using 2011-2020 nationwide outpatient claims data. Frontiers in Psychiatry. 2023;14:1264047.
  https://doi.org/10.3389/fpsyt.2023.1264047
• Scholle O, Asendorf M, Buck C, Grill S, Jones C, Kollhorst B, Riedel O, Schüz B, Haug U. Regional variations in outpatient antibiotic prescribing in Germany: A small area analysis based on claims data. Antibiotics. 2022;11(7):836.
  https://doi.org/10.3390/antibiotics11070836
• Riedel O, Klau S, Langner I, Bachmann CJ, Scholle O. Prevalence of multimodal treatment in children and adolescents with ADHD in Germany: A nationwide study based on health insurance data. Child and Adolescent Psychiatry and Mental Health. 2021;15:76.
  https://doi.org/10.1186/s13034-021-00431-0
• Scholle O, Kollhorst B, Riedel O, Bachmann CJ. First-time users of ADHD medication among children and adolescents in Germany: An evaluation of adherence to prescribing guidelines based on claims data. Frontiers in Psychiatry. 2021;12:653093.
  https://doi.org/10.3389/fpsyt.2021.653093
• Scholle O, Neubert A, Riedel O, Toni I, Haug U. Repeated use of prescription drugs in pediatrics: Comprehensive overview based on German claims data. Frontiers in Pharmacology. 2021;12:706682.
  https://doi.org/10.3389/fphar.2021.706682
• Scholle O, Fegert JM, Kollhorst B, Öztürk E, Riedel O, Kölch M. Predictors for receiving medication and/or psychotherapy in children newly diagnosed with ADHD: A longitudinal population-based cohort study. Journal of Attention Disorders. 2020;24(2):255-264.
  https://doi.org/10.1177/1087054718816172
  https://repository.publisso.de/resource/frl%3A6417559
• Scholle O, Kollhorst B, Haug U. Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis. Journal of Internal Medicine. 2020;287(2):171-179.
  https://doi.org/10.1111/joim.12990
• Vassilev ZP, Soriano-Gabarró M, Kaye JA, Saltus CW, Riedel O, Scholle O, Mehtälä J, Korhonen P, Garbe E, Zong J. Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: Results from observational studies in three countries. Future Oncology. 2020;16(25):1889-1901.
  https://doi.org/10.2217/fon-2020-0315
• Langner I, Haug U, Scholle O, Lindemann C, Schröder C, Riedel O. Potential explanations for increasing methylphenidate use in children and adolescents with attention-deficit/hyperactivity disorder in Germany from 2004 to 2013. Journal of Clinical Psychopharmacology. 2019;39(1):39-45.
  https://doi.org/10.1097/JCP.0000000000000980
  https://repository.publisso.de/resource/frl%3A6423245
• Scholle O, Jilani H, Riedel O, Banaschewski T, Hadjigeorgiou C, Hunsberger M, Iguacel I, Molnár D, Pala V, Russo P, Veidebaum T, Zaqout M, Pohlabeln H, on behalf of the I.Family consortium. Use of nutritional supplements in youth with medicated and unmedicated attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 2019;29(1):58-65.
  https://doi.org/10.1089/cap.2018.0060
  https://repository.publisso.de/resource/frl%3A6423292
• Castellsagué J, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Calingaert B, Bui C, Arana A, Laguna C, Gonzalez-Rubio F, Roso-Llorach A, Prados-Torres A, Perez-Gutthan S. Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany. Pharmacoepidemiology and Drug Safety. 2018;27(9):953-961.
  https://doi.org/10.1002/pds.4584
• Scholle O, Banaschewski T, Enders D, Garbe E, Riedel O. Use and characteristics of antipsychotic/methylphenidate combination therapy in children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 2018;28(6):415-422.
  https://doi.org/10.1089/cap.2018.0024
  https://repository.publisso.de/resource/frl%3A6417060
• Castellsagué J, Perez-Gutthan S, Calingaert B, Bui C, Varas-Lorenzo C, Arana A, Prados-Torres A, Poblador-Plou B, Gonzalez-Rubio F, Giner-Soriano M, Roso-Llorach A, Kieler H, Linder M, Citarella A, Scholle O, Blenk T, Garbe E. Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany. Pharmacoepidemiology and Drug Safety. 2017;26(6):615-624.
  https://doi.org/10.1002/pds.4167

• Zeitschriftenartikel ohne peer-review

• Schäfer W, Scholle O, Viebrock J, Haug U. Verordnung von testosteronhaltigen Arzneimitteln in Deutschland. Bulletin zur Arzneimittelsicherheit - Informationen aus BfArM und PEI. 2025;3:4-8.
  https://www.bfarm.de/DE/Aktuelles/Publikationen/Bulletin/Ausgaben/_node.html
• Scholle O, Viebrock J, Haug U. Anwendung von opioidhaltigen Analgetika in Deutschland. Bulletin zur Arzneimittelsicherheit - Informationen aus BfArM und PEI. 2025;1:37-41.
  https://www.bfarm.de/DE/Aktuelles/Publikationen/Bulletin/Ausgaben/_node.html

• Bücher

• Scholle O. Beratungsscheibe Selbstmedikation. Eschborn. 2015.

• Dissertationen

• Scholle O. Nutzung medikamentöser und nicht-medikamentöser Therapien bei Kindern und Jugendlichen mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung: Primär- und Sekundärdaten-basierte Analysen. Bremen: Universität Bremen; 2020.
  https://doi.org/10.26092/elib/246

• Vorträge bei wissenschaftlichen Tagungen

• Enners S, Schlotmann A, Schüssel K, Brückner G, Jobski K, Langner I, Thiede M, Scholle O. District-level differences in opioid prescribing in Germany (2023): Results from a population-based study. Jena. 2025.
• Scholle O, Kollhorst B, Heinig M, Haug U. Real-world use of pembrolizumab in Germany: Patient characteristics and survival. Jena. 2025.
• Bachmann CJ, Bittner R, Riedel O, Scholle O. Verschreibung von Clozapin bei Menschen mit Schizophrenie in Deutschland: Prävalenz, zeitliche Trends und regionale Unterschiede im Zeitraum 2010-2021. Berlin. 2024.
• Scholle O, Jobski K, Viebrock J, Haug U. Wachsende regionale Unterschiede nach Urbanität und sozioökonomischer Benachteiligung in der Verschreibungsprävalenz von Opioid-Analgetika bei nicht-tumorbedingten Schmerzen: Ergebnisse basierend auf deutschen Krankenkassendaten von 2004 bis 2020. Bonn. 2024.
• Buck C, Scholle O, Kollhorst B, Haug U. Area-level analysis of regional socio-economic factors on outpatient antibiotic prescribing including claims data from 16 million persons in Germany. Würzburg. 2023.
• Scholle O, Jobski K, Viebrock J, Haug U. Prescribing of opioid analgesics in Germany: Opposite trends when different quantification measures are used. Halifax, Canada. 2023.
• Scholle O, Jobski K, Viebrock J, Haug U. Verschreibung von Opioid-Analgetika in Deutschland: Gegensätzliche Trends bei Verwendung unterschiedlicher Maßzahlen zur Quantifizierung. Köln. 2023.
• Schüz B, Jones C, Scholle O, Haug U. Regional variations in antibiotic prescribing in Germany: Understanding differences through an adapted theoretical domains framework. Bremen. 2023.
• Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Outpatient antibiotic prescribing in early life: A population-based study comparing birth cohorts from Denmark and Germany. Münster. 2022.
• Scholle O, Asendorf M, Buck C, Grill S, Riedel O, Haug U. Antibiotic prescribing in children aged 0-6 years in Germany: Assessing regional variations and potential explanations based on claims data. Online-Vortrag. 2021.
• Scholle O, Asendorf M, Buck C, Grill S, Riedel O, Haug U. Antibiotic prescribing in children aged 0-6 years in Germany: Assessing regional variations and potential explanations based on claims data. online presentation. 2021.
• Scholle O, Grill S, Haug U. Early life exposure to antibiotics: A comparison of birth cohorts based on German claims data. Online-Vortrag. 2020.
• Scholle O, Neubert A, Riedel O, Toni I, Haug U. Prevalence of chronic drug use in pediatrics: Comprehensive overview based on German claims data. Online-Vortrag. 2020.
• Scholle O, Kollhorst B, Haug U. Diclofenac use and cardiovascular contraindications: Risk minimisation measures lacking effectiveness in Germany - A claims data analysis. Ulm. 2019.
• Schröder C, Scholle O, Riedel O. Using administrative data to examine extent and risks of psychotropic drug use in children and adolescents. Possibilities and limitations. Munich. 2016.

• Vorträge bei wissenschaftlichen Tagungen (eingeladen)

• Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Ambulante Verordnung von Antibiotika im frühen Leben: Eine bevölkerungsbasierte Studie zum Vergleich von Geburtskohorten aus Dänemark und Deutschland. Bremen. 2024.
• Scholle O. Regionale Unterschiede bei ambulanten Antibiotikaverordnungen auf Kreis-Ebene: Einblicke in das SARA-Projekt. Bremen. 2023.
• Scholle O. German Pharmacoepidemiological Research Database (GePaRD): Möglichkeiten und Grenzen. Berlin. 2019.

• Poster bei wissenschaftlichen Tagungen

• Enners S, Schlotmann A, Schüssel K, Brückner G, Jobski K, Langner I, Thiede M, Scholle O. Regional variations in opioid prescribing in Germany on a district-level in 2023: A population-based study using claims data. Uppsala, Sweden. 2025.
• Schäfer W, Scholle O, Viebrock J, Haug U. Use of testosterone-containing drugs in Germany: Time trends and potential off-label use. Uppsala, Sweden. 2025.
• Scholle O, Jobski K, Viebrock J, Haug U. Use of transmucosal fentanyl in Germany (2005-2020): Insights from a large claims database. Uppsala, Sweden. 2025.
• Scholle O, Thiyagarajan A, Koenen N, Haug U. Regional variations in the use of thyroid stimulating hormone measurements and levothyroxine in Germany: A small area analysis based on claims data. Berlin. 2024.
• Scholle O, Buck C, Kollhorst B, Haug U. Explaining regional variations in outpatient antibiotic prescribing: A small area analysis including over 16 million persons in Germany. Halifax, Canada. 2023.
• Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Kaplan S, McMahon AW, Movva N, Raman SR, Scholle O, Suh M, Sun JW, Horton DB. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Halifax, Canada. 2023.
• Bliddal M, Bachmann CJ, DosReis S, Odsbu I, Scholle O, Skurtveit S, Vivirito A, Wesselhoeft R, Scott S. So many countries, so many customs: A register-based analysis of conduct disorder prevalence and treatment patterns in four western countries. Copenhagen, Denmark. 2022.
• Christ P, Rischke N, Dubrall D, Scholle O, Stausberg J, Haug U, Sachs B. WOLGA: Further development, optimization and application of an algorithm for the detection of serious adverse drug reactions based on claims data - First results of a sub-analysis focusing on clostridium difficile infections. Münster. 2022.
• Scholle O, Rasmussen L, Reilev M, Viebrock J, Haug U. Outpatient antibiotic prescribing in early life: A population-based study comparing birth cohorts from Denmark and Germany. Copenhagen, Denmark. 2022.
• Scholle O, Grill S, Haug U. Changes in early life exposure to antibiotics: A comparison of birth cohorts based on German claims data. online poster. 2020.
• Scholle O, Grill S, Haug U. Changes in early life exposure to antibiotics: A comparison of birth cohorts based on German claims data. Online-Poster. 2020.
• Scholle O, Neubert A, Riedel O, Toni I, Haug U. Prevalence of chronic drug use in pediatrics: Comprehensive overview based on German claims data. online poster. 2020.
• Scholle O, Neubert A, Riedel O, Toni I, Haug U. Prevalence of chronic drug use in pediatrics: Comprehensive overview based on German claims data. Online-Poster. 2020.
• Scholle O, Kollhorst B, Haug U. Are the risk minimization measures for diclofenac effective? A pre-post comparison based on German claims data. Philadelphia, USA. 2019.
• Kölch M, Fegert JM, Kollhorst B, Öztürk E, Riedel O, Scholle O. Predictors for pharmacological and psychotherapeutic treatment in children newly diagnosed with ADHD. Seattle, USA. 2018.
• Scholle O, Banaschewski T, Jilani H, Riedel O, Pohlabeln H. Gebrauch von Nahrungsergänzungsmitteln bei Kindern mit medikamentös und nicht medikamentös behandelter ADHS. Bremen. 2018.
• Scholle O, Fegert JM, Kollhorst B, Öztürk E, Riedel O, Kölch M. Predictors for pharmacological and psychotherapeutic treatment in children newly diagnosed with ADHD. Prague, Czech Republic. 2018.
• Castellsagué J, Calingaert B, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Arana A, Bui C, Laguna C, Prados-Torres A, Roso-Llorach A, Perez-Gutthan S. Impact of risk-minimization measures on the use of cilostazol in Europe. Montreal, Canada. 2017.
• Castellsagué J, Calingaert B, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Varas-Lorenzo C, Arana A, Bui C, Prados-Torres A, Gonzalez-Rubio F, Roso-Llorach A, Citarella A, Garbe E, Blenk T, Perez-Gutthan S. Characterization of new users of cilostazol in the United Kingdom, Spain, Sweden, and Germany. Dublin, Ireland. 2016.

• Weitere Publikationen

• Spotlight Poster Winner 2020 in the category of "Pediatrics"
  International Society for Pharmacoepidemiology (2020)
  Poster entitled "Changes in Early Life Exposure to Antibiotics: A Comparison of Birth Cohorts Based on German Claims Data"
• ICPE Scholarship 2019
  International Society for Pharmacoepidemiology (2019)
  Teilnahme an der 35. International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Philadelphia, PA, USA

• 2024 Seminar „Epidemiologie I“; Bachelorstudiengang Public Health/Gesundheitswissenschaft; Fachbereich 11: Human- und Gesundheitswissenschaften; Universität Bremen
• 2023/24 Wahlmodul „Pharmakoepidemiologie“; Masterstudiengang Public Health/Gesundheitswissenschaften; Technische Universität Dresden
• 2021/22 Wahlmodul Pharmakoepidemiologie im Masterstudiengang Public Health/Gesundheitswissenschaften an der Technischen Universität Dresden
• Mai 2014 bis April 2018 Fächer Pharmazie, pharmazeutisches Recht & allgemeine Pharmakologie in der Pharmaakademie GmbH & Co. KG